1695562-36-7
1695562-36-7
Chemical Structure
SXC2023
- CAS No.: 1695562-36-7
- Formula:C13H15NO4S
- Molecular Weight:281.33
IUPAC Name: 1-(4-chloro-2-methylphenyl)-2,2,2-trifluoroethan-1-ol
InChIKey: QHXPWGXGEBJOCG-NSHDSACASA-N
SMILES: CC(N[C@H](C(O)=O)CSC(C1=CC=C(C=C1)C)=O)=O
Biological Activity: SXC2023 is a glutamatergic reagent and cystine-glutamate antiporter (System xc−) activator. SXC2023 can affect SLC7A11. SXC2023 is applicable to the research of colorectal cancer and trichotillomania[1][2][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
SXC2023 | 99.85% | SXC2023 is a glutamatergic reagent and cystine-glutamate antiporter (System xc−) activator. SXC2023 can affect SLC7A11. SXC2023 is applicable to the research of colorectal cancer and trichotillomania. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Ahmadizad Firouzjaei A, et al. Regulation of ferroptosis in colorectal cancer through therapeutic modulation and miRNA targeting. Biochem Biophys Rep. 2026;45:102444. Published 2026 Jan 8. [Content Brief]
- [2]. CNS Summit: Selected Abstracts from the 2019 Meeting. Innov Clin Neurosci. 2019 Sep 1;16(9-10):S5-S19. [Content Brief]
- [3]. Stein DJ, et al. Body-Focused Repetitive Behavior Disorders: From Competing Paradigms Toward Iterative Integration. Annu Rev Clin Psychol. 2026 May;22(1):481-503. [Content Brief]
